Anti-KLF16 body heightened serum CK-MB and CK levels, increased myocardial damage, induced LVEDD, LVESD and LVSD levels, and diminished LVEF level in mice with myocardial ischemia-reperfusion (Figure 3(a-g)). Here, KLF16 is linked to myocardial ischemia.